259 related articles for article (PubMed ID: 28000858)
21. ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis.
Meng W; Lu X; Wang G; Xiao Q; Gao J
Funct Integr Genomics; 2024 Mar; 24(2):53. PubMed ID: 38453820
[TBL] [Abstract][Full Text] [Related]
22. Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis.
Li X; Yu C; Luo Y; Lin J; Wang F; Sun X; Gao Y; Tan W; Xia Q; Kong X
Int J Biol Sci; 2021; 17(7):1782-1794. PubMed ID: 33994862
[TBL] [Abstract][Full Text] [Related]
23. Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer.
Xu M; Xi S; Li H; Xia Y; Mei G; Cheng Z
Sci Rep; 2024 Mar; 14(1):6488. PubMed ID: 38499636
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer.
Maruyama R; Nagaoka Y; Ishikawa A; Akabane S; Fujiki Y; Taniyama D; Sentani K; Oue N
Pathol Int; 2022 Mar; 72(3):176-186. PubMed ID: 35147255
[TBL] [Abstract][Full Text] [Related]
25. Targeting a moonlighting function of aldolase induces apoptosis in cancer cells.
Gizak A; Wiśniewski J; Heron P; Mamczur P; Sygusch J; Rakus D
Cell Death Dis; 2019 Sep; 10(10):712. PubMed ID: 31558701
[TBL] [Abstract][Full Text] [Related]
26. ALDOLASE A regulates invasion of bladder cancer cells via E-cadherin-EGFR signaling.
Li J; Wang F; Gao H; Huang S; Cai F; Sun J
J Cell Biochem; 2019 Aug; 120(8):13694-13705. PubMed ID: 31081974
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity.
Tian W; Zhou J; Chen M; Qiu L; Li Y; Zhang W; Guo R; Lei N; Chang L
Sci Rep; 2022 Jul; 12(1):11632. PubMed ID: 35804089
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
[TBL] [Abstract][Full Text] [Related]
29. A Robust and Cost-Effective Luminescent-Based High-Throughput Assay for Fructose-1,6-Bisphosphate Aldolase A.
Cho EJ; Devkota AK; Stancu G; Edupunganti R; Debevec G; Giulianotti M; Houghten R; Powis G; Dalby KN
SLAS Discov; 2020 Oct; 25(9):1038-1046. PubMed ID: 32462959
[TBL] [Abstract][Full Text] [Related]
30. Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target.
Grandjean G; de Jong PR; James B; Koh MY; Lemos R; Kingston J; Aleshin A; Bankston LA; Miller CP; Cho EJ; Edupuganti R; Devkota A; Stancu G; Liddington RC; Dalby K; Powis G
Cancer Res; 2016 Jul; 76(14):4259-4269. PubMed ID: 27261507
[TBL] [Abstract][Full Text] [Related]
31. Aldolase A overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer.
Ye F; Chen Y; Xia L; Lian J; Yang S
Biochem Biophys Res Commun; 2018 Mar; 497(2):639-645. PubMed ID: 29453983
[TBL] [Abstract][Full Text] [Related]
32. Proteomic profiling of osteosarcoma cells identifies ALDOA and SULT1A3 as negative survival markers of human osteosarcoma.
Chen X; Yang TT; Zhou Y; Wang W; Qiu XC; Gao J; Li CX; Long H; Ma BA; Ma Q; Zhang XZ; Yang LJ; Fan QY
Mol Carcinog; 2014 Feb; 53(2):138-44. PubMed ID: 22949271
[TBL] [Abstract][Full Text] [Related]
33. Aldolase triggers metabolic reprogramming in colorectal cancer in hypoxia and stiff desmoplastic microenvironments.
Huang HC; Lin WR; Lim SN; Yeh CT; Yen TH; Alison MR; Chen CS
Colloids Surf B Biointerfaces; 2020 Jun; 190():110969. PubMed ID: 32199265
[TBL] [Abstract][Full Text] [Related]
34. SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance.
Munakata K; Uemura M; Takemasa I; Ozaki M; Konno M; Nishimura J; Hata T; Mizushima T; Haraguchi N; Noura S; Ikenaga M; Okamura S; Fukunaga M; Murata K; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2014 May; 44(5):1521-8. PubMed ID: 24585249
[TBL] [Abstract][Full Text] [Related]
35. A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity.
Sun J; He D; Fu Y; Zhang R; Guo H; Wang Z; Wang Y; Gao T; Wei Y; Guo Y; Pang Q; Liu Q
J Exp Clin Cancer Res; 2021 Jun; 40(1):187. PubMed ID: 34099027
[TBL] [Abstract][Full Text] [Related]
36. Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target.
Chen L; Wu Z; Guo J; Wang X; Zhao Z; Liang H; Zhang R; Deng J
Clin Exp Med; 2023 Oct; 23(6):2443-2456. PubMed ID: 36422738
[TBL] [Abstract][Full Text] [Related]
37. Fructose-1,6-bisphosphate aldolase A is involved in HaCaT cell migration by inducing lamellipodia formation.
Tochio T; Tanaka H; Nakata S; Hosoya H
J Dermatol Sci; 2010 May; 58(2):123-9. PubMed ID: 20362419
[TBL] [Abstract][Full Text] [Related]
38. The antitumor role of a newly discovered α-d-glucan from Holotrichia diomphalia Bates as a selective blocker of aldolase A.
Wang J; Li Z; Yang X; Qiao Y; Feng C; Yu S; Jing H; Liu W; Ren L; Duan Q; Li XQ; Cao W
Carbohydr Polym; 2021 Mar; 255():117532. PubMed ID: 33436261
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
[TBL] [Abstract][Full Text] [Related]
40. High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer.
Dai L; Pan G; Liu X; Huang J; Jiang Z; Zhu X; Gan X; Xu Q; Tan N
Cancer Manag Res; 2018; 10():1799-1806. PubMed ID: 29988738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
